Current in vitro and preclinical developments for investigational targeted toxins in glioblastoma.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Current_in_vitro_and_preclinical_developments_for_investigational_targeted_toxins_in_glioblastoma_/1225207
下载链接
链接失效反馈官方服务：
资源简介：
PE = whole Pseudomonas exotoxin; PE38 = truncated form of PE in which amino acids 1–252 and amino acids 365–380 are deleted; PE38KDEL = PE38 with a terminal lysyl-aspartyl-glutamyl-leucine sequence; DT = whole diphtheria toxin; DT389 & DT390 = first 389/390 amino acids of diphtheria toxin; AT-uPA & ATF = amino terminal fragments of urokinase-type plasminogen activator (uPA); uPAR = urokinase-type plasminogen activator receptor; HMW-MAA = high-molecular-weight melanoma-associated antigen; GPNMB = Glycoprotein NMB; EGF = epidermal growth factor; EGFR = epidermal growth factor receptor; EGFRvIII = mutant EGFR containing a deletion of 267 amino acids from the extracellular domain; IL-13 = Interleukin 13; IL13RA2 = interleukin 13 receptor, alpha 2; PTPRZ1 = receptor-type tyrosine-protein phosphatase zeta; 3′-isoLM1 and 3′,6′-isoLD1 = Glioma-associated foetal ganglioside antigens; NZ-1 = podoplanin.
Current in vitro and preclinical developments for investigational targeted toxins in glioblastoma.
创建时间：
2014-10-31
